A retrospective case-series of influence of chronic hepatitis B on synchronous liver metastasis of colorectal cancer
Open Access
- 23 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1109464
Abstract
Main point: Our retrospective analysis of a large number of cases found in patients with primary colorectal cancer (CRC) carrying positive HBsAg inhibited the occurrence of synchronous liver metastases (SLM). However, liver cirrhosis caused by non-HBV factors promoted the occurrence of SLM.Objectives: This study aimed to investigate the effect of HBV on the occurrence of synchronous liver metastases (SLM) of colorectal cancer (CRC).Methods: Univariate and multivariate analyses were used to analyze the influence of clinical parameters on the occurrence of SLM.Results: A total of 6, 020 patients with primary CRC were included in our study, of which 449 patients carrying HBsAg(+) accounted for 7.46%. 44 cases of SLM occurred in the HBsAg(+) group, accounting for 9.80%, which was much lower than 13.6% (758/5571) in the HBsAg(-) group (X=5.214, P=0.022). Among CRC patients with HBsAg(-), the incidence of SLM was 24.9% and 14.9% in the group with high APRI and FIB-4 levels, respectively, which were significantly higher than that in the compared groups (12.3% and 12.5%, all P<0.05). Compared with the control group, female patients, late-onset patients, and HBV-infective patients had lower risks of SLM (HR=0.737, 95%CI: 0.614-0.883, P<0.001; HR=0.752, 95%CI: 0.603-0.943, P=0.013; HR=0.682, 95%CI: 0.473-0.961, P=0.034).Conclusions: The carriage of HBsAg(+) status inhibited the occurrence of SLM from CRC. HBV-causing liver cirrhosis did not further influence the occurrence of SLM, whereas non-HBV-factor cirrhosis promoted the occurrence of SLM. Nevertheless, this still required prospective data validation.Keywords
This publication has 58 references indexed in Scilit:
- Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases2British Journal of Surgery, 2012
- HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort studyWorld Journal of Gastroenterology, 2011
- MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1Cancer Research, 2010
- Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single CenterAnnals of Surgical Oncology, 2009
- Liver cirrhosisThe Lancet, 2008
- FIB-4Hepatology, 2007
- Matrix metalloproteinase‐9,‐3 and tissue inhibitor of matrix metalloproteinase‐1 in colorectal cancer: relationship to clinicopathological variablesCell Biochemistry and Function, 2006
- Flow-mediated dilation in brachial artery in the second half of pregnancy and prediction of pre-eclampsiaJournal of Human Hypertension, 2003
- Colorectal Adenocarcinoma in Cirrhotic PatientsJournal of the American College of Surgeons, 2003
- The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytesHepatology, 1998